1260494-11-8

Basic information

• Product Name: tert-butyl 6-methyl-8-((4-4-(methylthio)phenyl)-2-oxopyridin-1(2H)-yl)-3,4,5,6-tetrahydroazepino[4,3-b]indole-2(1H)-carboxylate
• Synonyms: tert-butyl 6-methyl-8-((4-4-(methylthio)phenyl)-2-oxopyridin-1(2H)-yl)-3,4,5,6-tetrahydroazepino[4,3-b]indole-2(1H)-carboxylate
• CAS NO: 1260494-11-8
• Molecular Weight: 515.676
• Mol File: 1260494-11-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: tert-butyl 6-methyl-8-((4-4-(methylthio)phenyl)-2-oxopyridin-1(2H)-yl)-3,4,5,6-tetrahydroazepino[4,3-b]indole-2(1H)-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 6-methyl-8-((4-4-(methylthio)phenyl)-2-oxopyridin-1(2H)-yl)-3,4,5,6-tetrahydroazepino[4,3-b]indole-2(1H)-carboxylate(1260494-11-8)
• EPA Substance Registry System: tert-butyl 6-methyl-8-((4-4-(methylthio)phenyl)-2-oxopyridin-1(2H)-yl)-3,4,5,6-tetrahydroazepino[4,3-b]indole-2(1H)-carboxylate(1260494-11-8)

Safety Data

• Hazardous Substances Data: 1260494-11-8(Hazardous Substances Data)

Upstream product

• 1260494-00-5 7-bromo-9-methyl-2,3-dihydro-1H-carbazol-4(9H)-one oxime 
• 1260494-01-6 8-bromo-6-methyl-2,3,4,5-tetrahydroazepino[4,3-b]indol-1(6H)-one 
• 1260493-99-9 7-bromo-9-methyl-2,3-dihydro-1H-carbazol-4(9H)-one 
• 1260493-98-8 7-bromo-2,3-dihydro-1H-carbazol-4(9H)-one 
• 78863-99-7 7-bromo-2,3,4,9-tetrahydro-1H-carbazole 
• 108-94-1 cyclohexanone 
• 27246-81-7 3-bromophenylhydrazine hydrochloride 
• 1173157-45-3 4-(4-(methylthio)phenyl)pyridin-2(1H)-one 
• 1260494-02-7 tert-butyl 8-bromo-6-methyl-3,4,5,6-tetrahydroazepino[4,3-b]indole-2(1H)-carboxylate 

Downstream Products

• 1260491-97-1 1-(6-Methyl-1,2,3,4,5,6-hexahydroazepino[4,3-b]indol-8-yl)-4-(4-(methylthio)phenyl)pyridin-2(1H)-one hydrochloride 

Relevant articles and documents

AZINONE-SUBSTITUTED AZEPINO[b]INDOLE AND PYRIDO-PYRROLO-AZEPINE MCH-1 ANTAGONISTS, METHODS OF MAKING, AND USE THEREOF

Novel MCH-1 receptor antagonists are disclosed. These compounds are used in the treatment of various disorders, including obesity, anxiety, depression, non-alcoholic fatty liver disease, and psychiatric disorders. Methods of making these compounds are als